)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
CytoDyn
CytoDyn (CYDY) investor relations material
CytoDyn Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q2 2026 earnings summary9 Jan, 2026
Executive summary
Focused on clinical development of leronlimab for solid-tumor oncology, with ongoing Phase II trials and plans for additional studies and a long-acting version.
Significant additional funding is needed to execute the business strategy, with efforts to pursue both dilutive and non-dilutive financing.
In November 2025, reached an agreement in principle to settle a securities class action for $500,000 in cash and 49 million shares, subject to court approval.
Financial highlights
Net loss of $22.6 million for the quarter ended November 30, 2025, compared to a net loss of $4.8 million in the same quarter last year.
Six-month net loss was $28.1 million, compared to net income of $14.5 million in the prior year, which included a one-time $25 million clinical expense recovery.
Cash and cash equivalents decreased to $5.0 million as of November 30, 2025, from $11.9 million at May 31, 2025.
Operating expenses rose to $21.7 million for the quarter, driven by a $16.6 million legal settlement accrual.
Outlook and guidance
Substantial doubt exists about the ability to continue as a going concern due to recurring losses and accumulated deficit of $915.9 million.
Continuation depends on raising additional capital, successful development and approval of leronlimab, and generating future revenues.
Given the cash deficit, how will short-term liabilities be met?
Quantify impact if class action settlement fails
Total potential dilution from all equity instruments?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next CytoDyn earnings date
Q3 202610 Apr, 2026
CytoDyn
Next CytoDyn earnings date
Q3 202610 Apr, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
CytoDyn Inc. is a biotechnology company focused on the development of innovative treatments for infectious diseases, cancer, and immune-related conditions. The company specializes in monoclonal antibody therapies and explores applications in virology, immunology, and oncology. The company is headquartered in Vancouver, Washington, and its shares are listed on the OTCQB.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage